151 – 160 of 241
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone
(
- Contribution to journal › Article
-
Mark
Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR)
(
- Contribution to journal › Article
-
Mark
Mechanisms of hypertension in the cardiometabolic syndrome
(
- Contribution to journal › Scientific review
-
Mark
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
(
- Contribution to journal › Scientific review
-
Mark
Fibromuskulär dysplasi--angiopati som oftast drabbar njurartarerna. Angioplastik ger goda resultat då läkemedel inte förmhr kuva hypertonin.
(
- Contribution to journal › Scientific review
-
Mark
Behandling av aterosklerotisk njurartärstenos i förändring. Lågdos ACE-hämmare och angiotensin- receptorblockare motiverat i vissa fall.
(
- Contribution to journal › Scientific review
-
Mark
Pulmonell arteriell hypertension. Nya behandlingsprinciper ger förbättrad behandling vid ett ovanligt tillstånd.
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension The Nordic Diltiazem Study
(
- Contribution to journal › Article
-
Mark
Retinopathy in subjects with impaired fasting glucose The NANSY – Eye Study, Baseline report
(
- Contribution to journal › Article
- 2007
-
Mark
Risk factor control in treated hypertensives from Estonia and Sweden. Why the difference?
(
- Contribution to journal › Article